[ad_1]
Sacramento, Ca – 
The Investor Presentation is available at the link below where the Company expects to update it periodically:
“At Boon, we are intent on perpetually increasing our transparency to the investing public. Over the past year alone we’ve filed our Form 10 with the Securities and Exchange Commission and hired a highly experienced and respected Investor Relations firm to serve our valued shareholders,” stated Justin Gonzalez, CEO, Boon Industries. “Today, we’re making available a current Investor Presentation which we believe will help shed some light and insight into our operations, product, management team and our short and long term goals.”
About Boon Industries
Boon Industries, Inc. (OTC: BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon’s product offering is DiOx+™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
LinkedIn: https://www.linkedin.com/company/boon-industries
Twitter: https://twitter.com/boonindustries
Company Contact
Boon Industries, Inc.
Investor Relations & Financial Media
Integrity Media Inc.
Toll Free: (888) 216-3595
[ad_2]